Internal Medicine, Nephrology · Loris, SC
NPI
1679665608
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
3617 Casey St, Suite C
Loris, SC, 29569
Phone (843) 716-7163
Groups this clinician bills Medicare through
Medicare paid, 2024
$153K
1,895 services
Medicare patients, 2024
536
Average age 76
Drug cost, 2024
$1.8M
4,220 prescriptions
Company payments, 2025
$1,806
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher L Po was code 99213 (office e&m - established), 327 times for 209 patients. In total Christopher L Po billed 1,895 services in 32 codes, and Medicare paid $153K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 327 | 209 | $60.84 | $20K |
| 99214 Office E&M - Established | Office | 243 | 153 | $84.97 | $21K |
| 99232 Hospital E&M - Subsequent | Facility | 180 | 73 | $57.95 | $10K |
| 90960 ESRD Related Services (not dialysis) | Office | 179 | 23 | $241.99 | $43K |
| 99231 Hospital E&M - Subsequent | Facility | 172 | 69 | $36.49 | $6,276 |
| 81001 Clinical Chemistry | Office | 133 | 126 | $3.11 | $414 |
| 99222 Hospital E&M - Initial | Facility | 98 | 86 | $96.71 | $9,478 |
| 99309 SNF E&M | Facility | 97 | 48 | $66.89 | $6,489 |
| 99204 Office E&M - New | Office | 90 | 90 | $123.32 | $11K |
| 90935 Hemodialysis | Facility | 83 | 33 | $52.40 | $4,349 |
| 99309 SNF E&M | Office | 77 | 39 | $79.49 | $6,121 |
| 99306 SNF E&M | Facility | 24 | 24 | $136.05 | $3,265 |
| 36556 Venous Catheter Insertion | Facility | 20 | 18 | $62.52 | $1,250 |
| 99306 SNF E&M | Office | 18 | 17 | $136.51 | $2,457 |
| 99203 Office E&M - New | Office | 16 | 16 | $77.77 | $1,244 |
By year: 2022 $170K for 1,826 services; 2023 $150K for 1,575 services; 2024 $153K for 1,895 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81001 Clinical Chemistry | 133 | 126 | $3.11 | $414 |
Medicare prescription drug claims, 2024
In 2024, the drug Christopher L Po prescribed most often to Medicare patients was Losartan Potassium, with 232 prescriptions and refills. In total Christopher L Po wrote 4,220 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Losartan Potassium Generic | 232 | 508 | 81 | $2,022 |
| Furosemide Generic | 143 | 186 | 44 | $958 |
| Atorvastatin Calcium Generic | 141 | 199 | 33 | $2,218 |
| Farxiga Dapagliflozin Propanediol | 129 | 167 | 27 | $93K |
| Amlodipine Besylate Generic | 118 | 256 | 44 | $903 |
| Lisinopril Generic | 116 | 249 | 37 | $938 |
| Jardiance Empagliflozin | 112 | 138 | 24 | $74K |
| Sertraline Hcl Generic | 97 | 101 | 18 | $1,398 |
| Pantoprazole Sodium Generic | 92 | 153 | 27 | $1,158 |
| Eliquis Apixaban | 88 | 96 | 17 | $40K |
| Prednisone Generic | 87 | 123 | 43 | $508 |
| Levothyroxine Sodium Generic | 84 | 98 | 11 | $809 |
| Labetalol Hcl Generic | 81 | 149 | 28 | $1,843 |
| Tramadol Hcl Generic | 79 | 79 | 18 | $990 |
| Hydrochlorothiazide Generic | 78 | 171 | 28 | $257 |
Brand drugs: - claims; generic drugs: 3,519 claims; opioid claims: 173.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher L Po $1,806 ($1,806 in general payments such as food, travel and fees) from 24 companies. The largest payer was Calliditas Therapeutics US Inc. with $279.
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 6 | $279 |
| Amgen Inc. AMGN | 14 | $204 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 7 | $168 |
| ANI Pharmaceuticals, Inc. ANIP | 8 | $163 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $136 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $131 |
| Phathom Pharmaceuticals, Inc. PHAT | 4 | $114 |
| Mallinckrodt Hospital Products Inc. | 2 | $67.63 |
| Novo Nordisk Inc NVO | 3 | $66.24 |
| Travere Therapeutics, Inc. TVTX | 3 | $53.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.